Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Alpex Pharma (UK) Limited, Warren Plantation Church End, Haynes, Bedford, MK45 3RJ, UK Contact address: PO BOX 849, Bedford, MK45 9EG
Meloxicam 7.5 mg Orodispersible Tablets.
| Pharmaceutical Form |
|---|
|
Orodispersible Tablet. Round light yellow, flat tablet embossed with AX6 on one side. |
Meloxicam 7.5 mg.
Excipients:
E421: Mannitol 126.3 mg
E420: Sorbitol 20 mg
E951: Aspartame 4 mg
For other Excipients See 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Meloxicam |
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam family, with anti-inflammatory, analgesic and antipyretic properties. The anti-inflammatory activity of meloxicam has been proven in classical models of inflammation. As with other NSAID, its precise mechanism of action remains unknown. However, there is at least one common mode of action shared by all NSAID (including meloxicam): inhibition of the biosynthesis of prostaglandins, known inflammation mediators. |
| List of Excipients |
|---|
|
E421: Mannitol |
Boxes containing 2 Alu/PA-Alu-PVC blister packs of 10 tablet each.
Boxes containing 3 Alu/PA-Alu-PVC blister packs of 10 tablet each.
Boxes with one polyethylene bottle with polypropylene child-resistant tamper evident screw cap with desiccant containing 30 tablets each.
Boxes with one polyethylene bottle with polypropylene child-resistant tamper evident screw cap with desiccant containing 200 tablets each.
Alpex Pharma (UK) Limited, Warren Plantation – Church End, Haynes, Bedford, MK45 3RJ, UK
Contact address: PO BOX 849, Bedford, MK45 9EG
PL 31388/0003
07/08/2009
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
